We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

2019-2027 Amifostine Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

This report studies the Amifostine market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Amifostine market by product type and applications/end industries.

Consumption of amifostine mainly concentrates in North America. In 2016, the region consumed 780 K Unit, holding about 52% market share globally. The follower is Asia-Pacific, with about 41% consumption share.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Amifostine in these regions, from 2012 to 2023 (forecast), covering
United States
North America
Europe
Asia-Pacific
South America

The major players in global and United States Amifostine market, including
Clinigen Group
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma


On the basis of product, the Amifostine market is primarily split into
400mg/Dose
500mg/Dose
On the basis on the end users/applications, this report covers

Ovarian Cancer Adjuvant Therapy
Head and Neck Cancer Adjuvant Therapy
Others




Table of Contents

1 Amifostine Market Overview 1
1.1 Amifostine Product Overview 1
1.2 Global Amifostine Product Segment by Type 3
1.2.1 Global Amifostine Sales (K Unit) and Growth (%) by Types (2012, 2016 and 2023) 3
1.2.2 Global Amifostine Sales (K Unit) and Market Share (%) by Types (2012-2017) 4
1.2.3 Global Amifostine Revenue (Million USD) and Market Share (%) by Types (2012-2017) 4
1.2.4 Global Amifostine Price (USD/Unit) by Type (2012-2017) 5
1.3 United States Amifostine Product Segment by Type 6
1.3.1 United States Amifostine Sales (K Unit) and Growth by Types (2012, 2016 and 2023) 6
1.3.2 United States Amifostine Sales (K Unit) and Market Share by Types (2012-2017) 6
1.3.3 United States Amifostine Revenue (Million USD) and Market Share by Types (2012-2017) 6
1.3.4 United States Amifostine Price (USD/Unit) by Type (2012-2017) 7
2 Amifostine Application/End Users 8
2.1 Amifostine Segment by Application/End Users 8
2.2 Global Amifostine Product Segment by Application 8
2.2.1 Global Amifostine Sales (K Unit) and CGAR (%) by Applications (2012, 2016 and 2023) 8
2.2.2 Global Amifostine Sales (K Unit) and Market Share (%) by Applications (2012-2017) 8
2.3 United States Amifostine Product Segment by Application 9
2.3.1 United States Amifostine Sales (K Unit) and CGAR (%) by Applications (2012, 2016 and 2023) 9
2.3.2 United States Amifostine Sales (K Unit) and Market Share (%) by Applications (2012-2017) 10
3 Amifostine Market Status and Outlook by Regions 12
3.1 Global Market Status and Outlook by Regions 12
3.1.1 Global Amifostine Market Size and CAGR by Regions (2012, 2016 and 2023) 12
3.1.2 North America 12
3.1.3 Asia-Pacific 13
3.1.4 Europe 14
3.1.5 South America 15
3.1.6 United States 16
3.2 Global Amifostine Sales and Revenue by Regions 17
3.2.1 Global Amifostine Sales (K Unit) and Market Share (%) by Regions (2012-2017) 17
3.2.2 Global Amifostine Revenue (Million USD) and Market Share (%) by Regions (2012-2017) 19
3.2.3 Global Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 21
3.2.4 North America Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 22
3.2.5 Europe Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 22
3.2.6 Asia-Pacific Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 23
3.2.7 South America Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) 23
3.2.8 United States Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) 24
4 Global Amifostine Market Competition by Players/Manufacturers 25
4.1 Global Amifostine Sales (K Unit) and Market Share by Players (2012-2017) 25
4.2 Global Amifostine Revenue (Million USD) and Share by Players (2012-2017) 27
4.3 Global Amifostine Average Price (USD/Unit) by Players (2012-2017) 29
4.4 Global Top Players Amifostine Manufacturing Base Distribution, Sales Area 30
4.5 Amifostine Market Competitive Situation and Trends 31
4.5.1 Amifostine Market Concentration Rate 31
4.5.2 Global Amifostine Market Share (%) of Top 3 and Top 5 Players 32
4.5.3 Mergers & Acquisitions, Expansion 33
5 United States Amifostine Market Competition by Players/Manufacturers 34
5.1 United States Amifostine Sales (K Unit) and Market Share by Players (2012-2017) 34
5.2 United States Amifostine Revenue (Million USD) and Share by Players (2012-2017) 36
5.3 United States Amifostine Average Price (USD/Unit) by Players (2012-2017) 37
6 Amifostine Players/Manufacturers Profiles and Sales Data 38
6.1 Clinigen Group 38
6.1.1 Company Basic Information, Manufacturing Base and Competitors 38
6.1.2 Amifostine Product Category and Specification 39
6.1.3 Clinigen Group Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 39
6.1.4 Main Business/Business Overview 41
6.2 Sun Pharmaceutical 41
6.2.1 Company Basic Information, Manufacturing Base and Competitors 41
6.2.2 Amifostine Product Picture 42
6.2.3 Sun Pharmaceutical Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 42
6.2.4 Main Business/Business Overview 44
6.3 Taj Pharmaceuticals 44
6.3.1 Company Basic Information, Manufacturing Base and Competitors 44
6.3.2 Amifostine Product Category and Specification 45
6.3.3 Taj Pharmaceuticals Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 45
6.3.4 Main Business/Business Overview 47
6.4 Merro Pharmaceutical 47
6.4.1 Company Basic Information, Manufacturing Base and Competitors 47
6.4.2 Amifostine Product Category and Specification 49
6.4.3 Merro Pharmaceutical Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 49
6.4.4 Main Business/Business Overview 51
6.5 Luye Pharma 51
6.5.1 Company Basic Information, Manufacturing Base and Competitors 51
6.5.2 Amifostine Product Picture 52
6.5.3 Luye Pharma Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 53
6.5.4 Main Business/Business Overview 54
6.6 Mingren Pharma 54
6.6.1 Company Basic Information, Manufacturing Base and Competitors 54
6.6.2 Amifostine Product Picture 55
6.6.3 Mingren Pharma Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 56
6.6.4 Main Business/Business Overview 57
7 Amifostine Manufacturing Cost, Industrial Chain and Downstream Buyers 58
7.1 Amifostine Key Raw Materials Analysis 58
7.1.1 Key Raw Materials 58
7.1.2 Price Trend of Key Raw Materials 58
7.1.3 Key Suppliers of Raw Materials 60
7.1.4 Market Concentration Rate of Raw Materials 61
7.2 Proportion of Manufacturing Cost Structure 62
7.2.1 Raw Materials 62
7.2.2 Labor Cost 62
7.2.3 Manufacturing Expenses 62
7.3 Amifostine Industrial Chain Analysis 63
7.4 Manufacture Process Analysis of Amifostine 64
8 Marketing Strategy Analysis, Distributors and Market Effect Factors 65
8.1 Marketing Channel 65
8.1.1 Direct Marketing 65
8.1.2 Indirect Marketing 67
8.1.3 Marketing Channel Development Trend 68
8.2 Distributors in Untied States 69
8.3 Market Effect Factors Analysis 70
8.3.1 Economic/Political Environmental Change 70
8.3.2 Downstream Demand Change 70
8.3.3 Technology Progress in Related Industry 70
8.3.4 Substitutes Threat 71
9 Global Amifostine Market Forecast 72
9.1 Global Amifostine Sales, Revenue Forecast (2018-2023) 72
9.1.1 Global Amifostine Sales (K Unit) and Growth Rate (%) Forecast (2018-2023) 73
9.1.2 Global Amifostine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) 74
9.2 United States Amifostine Market Forecast 75
9.2.1 United States Amifostine Sales (K Unit) and Growth Rate (%) Forecast (2018-2023) 75
9.2.2 United States Amifostine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) 76
9.3 Global Amifostine Forecast by Regions 76
9.3.1 North America Amifostine Sales (K Unit) and Revenue (Million USD) Forecast (2018-2023) 78
9.3.2 Europe Amifostine Sales (K Unit) and Revenue (Million USD) Forecast (2018-2023) 80
9.3.3 Asia-Pacific Amifostine Sales (K Unit) and Revenue (Million USD) Forecast (2018-2023) 81
9.3.4 South America Amifostine Sales (K Unit) and Revenue (Million USD) Forecast (2018-2023) 83
9.4 Amifostine Forecast by Application 84
9.4.1 Global Amifostine Sales (K Unit) Forecast by Application (2018-2023) 84
9.4.2 United States Amifostine Sales (K Unit) Forecast by Application (2018-2023) 85
10 Research Findings and Conclusion 87
11 Methodology and Data Source 88
11.1 Methodology/Research Approach 88
11.1.1 Research Programs/Design 88
11.1.2 Market Size Estimation 90
11.1.3 Market Breakdown and Data Triangulation 92
11.2 Data Source 93
11.2.1 Secondary Sources 93
11.2.2 Primary Sources 94
11.3 Disclaimer 95
11.4 Author List 96



List of Tables and Figures

Figure Amifostine Product Picture 1
Figure Global Amifostine Revenue (Million USD) Status and Outlook (2012-2023) 2
Figure United States Amifostine Revenue (Million USD) Status and Outlook (2012-2023) 3
Table Global Amifostine Sales (K Unit) and Growth Rate (%) Comparison by Types (2012, 2016 and 2023) 3
Table Global Amifostine Sales (K Unit) by Types (2012-2017) 4
Figure Global Sales Amifostine Market Share (%) by Types in 2016 4
Table Global Amifostine Revenue (Million USD) by Types (2012-2017) 4
Figure 2016 Global Amifostine Revenue Market Share (%) by Types 5
Table Global Amifostine Price (USD/Unit) by Types (2012-2017) 5
Table United States Amifostine Sales (K Unit) and Growth Rate (%) Comparison by Types (2012, 2016 and 2023) 6
Table United States Amifostine Sales (K Unit) by Types (2012-2017) 6
Table United States Amifostine Revenue (Million USD) by Types (2012-2017) 6
Table United States Amifostine Price (USD/Unit) by Types (2012-2017) 7
Table Global Amifostine Sales (K Unit) Comparison by Applications (2012-2023) 8
Table Global Amifostine Sales (K Unit) by Applications (2012-2017) 8
Figure Global Sales Amifostine Market Share (%) by Applications in 2016 9
Table United States Amifostine Sales (K Unit) Comparison by Applications (2012-2023) 9
Table United States Amifostine Sales (K Unit) by Applications (2012-2017) 10
Figure United States Amifostine Sales Market Share (%) by Applications in 2016 10
Table Global Amifostine Revenue (Million USD) and CAGR Comparison by Regions (2012-2023) 12
Figure North America Amifostine Revenue (Million USD) and Growth Rate (%) (2012-2023) 13
Figure Asia-Pacific Amifostine Revenue (Million USD) and Growth Rate (%) (2012-2023) 14
Figure Europe Amifostine Revenue (Million USD) and Growth Rate (%) (2012-2023) 15
Figure South America Amifostine Revenue (Million USD) and Growth Rate (%) (2012-2023) 16
Figure United States Amifostine Revenue (Million USD) and Growth Rate (%) (2012-2023) 17
Table Global Amifostine Sales (K Unit) by Regions (2012-2017) 17
Table Global Amifostine Sales Market Share (%) by Regions (2012-2017) 18
Figure 2016 Global Amifostine Sales Market Share (%) by Regions 18
Figure 2012-2017 United States Amifostine Sales Market Share (%) in Global Market 19
Table Global Amifostine Revenue (Million USD) by Regions (2012-2017) 19
Table Global Amifostine Revenue Market Share (%) by Regions (2012-2017) 19
Figure 2016 Global Amifostine Revenue Market Share (%) by Regions 20
Figure 2012-2017 United States Amifostine Revenue Market Share (%) in Global Market 21
Table Global Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 21
Table North America Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 22
Table Europe Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 22
Table Asia-Pacific Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 23
Table South America Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 23
Table United States Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 24
Table Global Amifostine Sales (K Unit) of Key Players (2012-2017) 25
Table Global Amifostine Sales Share (%) by Players (2012-2017) 25
Figure 2016 Global Amifostine Sales Share (%) by Players 26
Figure 2017 Global Amifostine Sales Share (%) by Players 27
Table Global Amifostine Revenue (Million USD) by Players (2012-2017) 27
Table Global Amifostine Revenue Share (%) by Players (2012-2017) 28
Figure 2016 Global Amifostine Revenue Share (%) by Players 28
Figure 2017 Global Amifostine Revenue Share (%) by Players 29
Table Global Market Amifostine Average Price (USD/Unit) by Players (2012-2017) 29
Table Global Amifostine Top Players Manufacturing Base Distribution and Sales Area 30
Figure Amifostine Market Concentration Rate in 2016 31
Figure Global Amifostine Market Share (%) of Top 3 Players 32
Figure Global Amifostine Market Share (%) of Top 5 Players 32
Table United States Amifostine Sales (K Unit) by Players (2012-2017) 34
Table United States Amifostine Sales Market Share (%) by Players (2012-2017) 34
Figure 2016 United States Amifostine Sales Share (%) by Players 35
Figure 2017 United States Amifostine Sales Share (%) by Players 35
Table United States Amifostine Revenue (Million USD) by Players (2012-2017) 36
Figure 2016 United States Amifostine Revenue Share (%) by Players 36
Figure 2017 United States Amifostine Revenue Share (%) by Players 37
Table United States Market Amifostine Average Price (USD/Unit) by Players (2012-2017) 37
Table Clinigen Group Basic Information List 38
Table Amifostine Product Specification 39
Table Clinigen Group Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 39
Figure Clinigen Group Amifostine Sales Growth Rate (2012-2017) 40
Figure Clinigen Group Amifostine Sales Global Market Share (%) (2012-2017) 40
Table Sun Pharmaceutical Basic Information List 41
Figure Amifostine Product Picture of Sun Pharmaceutical 42
Table Sun Pharmaceutical Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 42
Figure Sun Pharmaceutical Amifostine Sales Growth Rate (2012-2017) 43
Figure Sun Pharmaceutical Amifostine Sales Global Market Share (%) (2012-2017) 43
Table Taj Pharmaceuticals Basic Information List 44
Table Amifostine Product Category and Specification of Taj Pharmaceuticals 45
Table Taj Pharmaceuticals Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 45
Figure Taj Pharmaceuticals Amifostine Sales Growth Rate (2012-2017) 46
Figure Taj Pharmaceuticals Amifostine Sales Global Market Share (%) (2012-2017) 47
Table Merro Pharmaceutical Basic Information List 47
Table Amifostine Product Category and Specification of Merro Pharmaceutical 49
Table Merro Pharmaceutical Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 49
Figure Merro Pharmaceutical Amifostine Sales Growth Rate (2012-2017) 50
Figure Merro Pharmaceutical Amifostine Sales Global Market Share (%) (2012-2017) 51
Table Luye Pharma Basic Information List 51
Figure Amifostine Product Picture of Luye Pharma 52
Table Luye Pharma Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 53
Figure Luye Pharma Amifostine Sales Growth Rate (2012-2017) 53
Figure Luye Pharma Amifostine Sales Global Market Share (%) (2012-2017) 54
Table Mingren Pharma Basic Information List 54
Figure Amifostine Product Picture of Mingren Pharma 55
Table Mingren Pharma Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 56
Figure Mingren Pharma Amifostine Sales Growth Rate (2012-2017) 56
Figure Mingren Pharma Amifostine Sales Global Market Share (%) (2012-2017) 57
Table List of Raw Materials of Amifostine Trihydrate 58
Figure US Acetone FOB US Export Price 2016-2017 59
Figure Global Acrylonitrile Average Price 2011-2016 59
Table Key Suppliers of Raw Materials 60
Figure 2016 Global Acrylonitrile Consumption Market Share by Regions 61
Figure 2015 Methanol Sales Share by Regions 61
Figure Manufacturing Cost Structure of Amifostine 62
Figure Amifostine Industrial Chain Analysis 63
Figure Manufacture Process Analysis of Amifostine 64
Figure Marketing Channels of Amifostine 68
Table Amifostine Technology Progress Analysis 70
Figure Global Amifostine Sales (K Unit) and Growth Rate (%) Forecast (2018-2023) 73
Figure Global Amifostine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) 74
Figure United States Amifostine Sales (K Unit) and Growth Rate (%) Forecast (2018-2023) 75
Figure United States Amifostine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) 76
Table Global Amifostine Sales (K Unit) Forecast by Regions (2018-2023) 76
Figure Global Amifostine Sales Market Share (%) Forecast by Regions (2018-2023) 77
Figure North America Amifostine Sales (K Unit) and Growth Rate (%) Forecast (2018-2023) 78
Figure North America Amifostine Revenue and Growth Rate (%) Forecast (2018-2023) 79
Figure Europe Amifostine Sales (K Unit) and Growth Rate (%) Forecast (2018-2023) 80
Figure Europe Amifostine Revenue and Growth Rate (%) Forecast (2018-2023) 80
Figure Asia-Pacific Amifostine Sales (K Unit) and Growth Rate (%) Forecast (2018-2023) 81
Figure Asia-Pacific Amifostine Revenue and Growth Rate (%) Forecast (2018-2023) 82
Figure South America Amifostine Sales (K Unit) and Growth Rate (%) Forecast (2018-2023) 83
Figure South America Amifostine Revenue and Growth Rate (%) Forecast (2018-2023) 84
Table Global Amifostine Sales (K Unit) Forecast by Application (2018-2023) 84
Figure Global Amifostine Sales Forecast by Application in 2023 85
Table United States Amifostine Sales (K Unit) Forecast by Application (2018-2023) 85
Figure United States Amifostine Sales Forecast by Application in 2023 86
Table Research Programs/Design for This Report 88
Figure Bottom-up and Top-down Approaches for This Report 91
Figure Data Triangulation 92
Table Key Data Information from Secondary Sources 93
Table Key Data Information from Primary Sources 94

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved